2-(4-Trifluoromethylphenyl)piperazine,
185110-19-4,
2-[4-(trifluoromethyl)phenyl]piperazine,
2-(4-(Trifluoromethyl)phenyl)piperazine,
AK-16316,
2-(4-TRIFLUOROMETHYL-PHENYL)-PIPERAZINE,
AC1MU24A,
AC1Q4J2V,
SCHEMBL1638129,
CTK4D8921,
DTXSID80394752,
NLNCQJXRJLNBOU-UHFFFAOYSA-N,
KS-00003KS7,
ANW-52037,
MFCD05864678,
SBB097587,
AKOS015852998,
2-(4-Trifluoromethyl-phenyl)piperazine,
2-(4-trifluoromethylphenyl)-piperazine,
FS-2835,
PB27708,
ACM185110194,
BR-16316,
AB0023022,
AX8062645,
DB-001856,
Piperazine,2-[4-(trifluoromethyl)phenyl]-,
ST2416132,
TR-008550,
4CH-014682,
CS-0054834,
FT-0655044,
Piperazine, 2-[4-(trifluoromethyl)phenyl]-,
W4004,
S-4670,
(+/-)-2-[4-(Trifluoromethyl)phenyl]piperazine,
2-(4-trifluoromethylphenyl)piperazine, AldrichCPR,
A812924,
I14-3776,
C11H13F3N2,
CID3659177,